Emergent Biosolutions
EBS
EBS
198 hedge funds and large institutions have $524M invested in Emergent Biosolutions in 2022 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 87 increasing their positions, 49 reducing their positions, and 39 closing their positions.
Holders
198
Holders Change
-13
Holders Change %
-6.16%
% of All Funds
3.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
29
Increased
87
Reduced
49
Closed
39
Calls
$877K
Puts
$595K
Net Calls
+$282K
Net Calls Change
+$516K
Top Buyers
| 1 |
1
State Street
Boston,
Massachusetts
|
$68.7M |
| 2 |
2
Invesco
Atlanta,
Georgia
|
$25.1M |
| 3 |
3
D.E. Shaw & Co
New York
|
$19.3M |
| 4 |
4
BlackRock
New York
|
$106M |
| 5 |
5
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
$9.89M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
CG
226
Cutler Group
San Francisco,
California
| – | -$4K | -203 | Closed |
|
|
FHA
227
First Horizon Advisors
Memphis,
Tennessee
| – | -$3K | -144 | Closed |
|
|
WWM
228
Wagner Wealth Management
Greenville,
South Carolina
| – | -$2K | -100 | Closed |
|
229
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| – | -$2K | -92 | Closed |
|
|
TAIM
230
TD Ameritrade Investment Management
Omaha,
Nebraska
| – | -$1K | -38 | Closed |
|
|
SWA
231
Sutton Wealth Advisors
Tampa,
Florida
| – | -$231 | -11 | Closed |
|